经导管动脉栓塞治疗婴儿颌面部巨大血管瘤

目的 评价婴儿颌面部巨大血管瘤,行经导管动脉栓塞治疗的疗效及安全性.方法 选择2005年至2007年间我院25例婴儿颌面部巨大血管瘤连续病例,行经股动脉插管血管瘤硬化栓塞(TASE)治疗,血管瘤供血动脉插管依次使用碘油博来霉素乳剂及聚乙烯醇泡沫颗粒栓塞.结果 25例共行TASE术35次,每例行1～3次,平均1.4次.平均住院3.2 d(2～5 d).25例中达治愈标准19例(76.0%),达显效标准6例(24.0%),无效0例,显效率100%,治疗结束后平均随访10.4个月,最长16个月,最短6个月,无复发病例.本组未出现肺栓塞、脑栓塞等严重并发症.结论 婴儿巨大血管瘤经导管动脉硬化栓塞治疗具有创伤小、安全、住院时间短、疗效显著、大多数病例术后不留瘢痕等优点.

Transcatheter arterial embolization in the treatment of huge maxillofacial hemangioma in infants

Objective To evaluate the therapeutic effects and safety of transcatheter arterial em-bolization (TAE) in infantile huge hemangiomas. Methods From 2005 to 2007, 25 consecutive cases of huge hemangioma that aged 1- 9mon ( mean 3.7±1.34 mon) and weighed 4.3 to 8kg (mean 6.52 ±0.86 kg) were treated by TAE. The support artery of hemangioma was embolized by Bleomycin-lip-iodol emulsion (PLE) and Polyvinyl Alcohol (PVA) in succession. Results Twenty-five cases under-went 35 times of TAE (1-3 times per each case with a mean of 1.4 times). The average hospitalization was 3.2 days (range 2-5 d ). The effective rate was 100% (25/25). The average follow-up period was 10. 44 months (range 6-16 months) without relapse. No serious complications such as pulmonary em-bolism and cerebral embolism occurred. Conclusions The advantages of TAE in the treatment for huge hernangioma in infancy are safe , effective, less trauma, short hospitalization and good cosmetic out-come.